- Conditions
- Congenital Bleeding Disorder, Congenital FXIII Deficiency
- Interventions
- catridecacog
- Drug
- Lead sponsor
- Novo Nordisk A/S
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 11 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003
- U.S. locations
- 1
- States / cities
- Los Angeles, California
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–9
of 9
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Factor XIII Deficiency
- Interventions
- FXIII Concentrate (Human)
- Biological
- Lead sponsor
- CSL Behring
- Industry
- Eligibility
- Not listed
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 5
- States / cities
- Dothan, Alabama • Orange, California • San Francisco, California + 2 more
- Conditions
- Congenital Bleeding Disorder, Congenital FXIII Deficiency
- Interventions
- catridecacog
- Drug
- Lead sponsor
- Novo Nordisk A/S
- Industry
- Eligibility
- 6 Years and older
- Enrollment
- 41 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 11
- States / cities
- Phoenix, Arizona • Orange, California • Tampa, Florida + 8 more
- Conditions
- Congenital Bleeding Disorder, Congenital FXIII Deficiency
- Interventions
- catridecacog
- Drug
- Lead sponsor
- Novo Nordisk A/S
- Industry
- Eligibility
- 1 Year to 6 Years
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2015
- U.S. locations
- 2
- States / cities
- Boston, Massachusetts • Columbus, Ohio
- Conditions
- Congenital Bleeding Disorder, Congenital FXIII Deficiency
- Interventions
- catridecacog
- Drug
- Lead sponsor
- Novo Nordisk A/S
- Industry
- Eligibility
- 1 Year to 6 Years
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2012
- U.S. locations
- 4
- States / cities
- Boston, Massachusetts • Detroit, Michigan • Minneapolis, Minnesota + 1 more
- Conditions
- Hemophilia, Factor XIII Deficiency
- Interventions
- Fibrogammin P
- Drug
- Lead sponsor
- Children's Hospital of Orange County
- Other
- Eligibility
- Not listed
- Enrollment
- 72 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2000 – 2011
- U.S. locations
- 1
- States / cities
- Orange, California
- Conditions
- Factor XIII Deficiency
- Interventions
- FXIII Concentrate (Human) (FXIII)
- Biological
- Lead sponsor
- CSL Behring
- Industry
- Eligibility
- Not listed
- Enrollment
- 61 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 25
- States / cities
- Dothan, Alabama • Oakland, California • Orange, California + 22 more
- Conditions
- Congenital Bleeding Disorder, Congenital FXIII Deficiency
- Interventions
- catridecacog
- Drug
- Lead sponsor
- Novo Nordisk A/S
- Industry
- Eligibility
- 6 Years and older
- Enrollment
- 63 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2015
- U.S. locations
- 12
- States / cities
- Orange, California • Washington D.C., District of Columbia • Tampa, Florida + 9 more
- Conditions
- Factor XIII Deficiency
- Interventions
- FXIII Concentrate (Human)
- Biological
- Lead sponsor
- CSL Behring
- Industry
- Eligibility
- Not listed
- Enrollment
- 41 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 22
- States / cities
- Dothan, Alabama • Oakland, California • Orange, California + 19 more